Australia is carefully awaiting the arrival of retatrutide, a novel dual GIP and GLP-1 receptor agonist that's generating significant buzz in the global weight management landscape. Developed by Novo Nordisk, this https://nettielcdb217971.wikiconverse.com/6632137/this_new_drug_retatrutide_australia_a_new_solution_for_weight_management